ArticleProcedia computer science2023
A non-invasive method for prediction of neurodegenerative diseases using gait signal features.
Article in Procedia computer science, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.
- Machine learning based algorithms for virtual early detection and screening of neurodegenerative and neurocognitive disorders: a systematic-review.Frontiers in neurology · 2024Pooled it
- Demographic Shortcuts Account for Most of the Apparent Accuracy of Four-Class Gait-Based Differential Diagnosis in Neurodegenerative Disease: An Interpretability-Driven Audit of Machine Learning on a Public Gait Benchmark.Bioengineering (Basel, Switzerland) · 2026Article
- A new parallel-path ConvMixer neural network for predicting neurodegenerative diseases from gait analysis.Medical & biological engineering & computing · 2025Article
- Syndrome Pattern Recognition Method Using Sensed Patient Data for Neurodegenerative Disease Progression Identification.Diagnostics (Basel, Switzerland) · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
The steady degeneration of neurons is the hallmark of neurodegenerative illnesses, which are, by definition, incurable. Corticobasal Syndrome (CS), Huntington's Disease (HD), Dementia, Amyotrophic Lateral Sclerosis (ALS), Progressive supranuclear palsy (PSP) and Parkinson's Disease (PD) are some of the common neurodegenerative diseases which has impacted millions of people, predominantly among the older population. Various computational techniques, including but not limited to machine learning, are emerging as discrimination and detection of neuro-related diseases. This research proposed a machine learning-based framework to correctly detect PD, HD, and ALS from the gait signals of subjects both in binary and multi-class detection environment. The detection approach proposed here combines the classification power of Naïve Bayes and Logistic Regression jointly in a modern UltraBoost ensemble framework. The proposed method is unique in its ability to detect neuro diseases with a small number of gait features. The proposed approach ascertains most essential gait features through three state-of-the-art feature selection schemes, infinite feature selection, infinite latent feature selection and Sigmis feature selection. It has been observed that the gait signal features of the subjects are identified through Infinite Feature Selection manifests better detection results than the features obtained through Infinite Latent Feature and Sigmis feature selection while detecting Parkinson's and Huntington's Disease in a multi-class environment. So far as the binary detection environment is concern, the Amyotrophic lateral sclerosis is detected with 99.1% detection accuracy using 18 Sigmis gait features, with 99.1% sensitivity and 98.9% specificity, respectively. Similarly, Huntington's disease was detected with 94.2% detection accuracy, 94.2% sensitivity, and 94.5% specificity using 5 Sigmis gait features. Finally, Parkinson's disease was detected with 98.4% sensitivity, specificity, and detection accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.